Ghaffari, A., Peterson, N., Khalaj, K., Vitkin, N., Robinson, A., Francis, J., & Koti, M. (2018). STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer. Br J Cancer.

Ghaffari, Abdi, Nichole Peterson, Kasra Khalaj, Natasha Vitkin, Andrew Robinson, Julie-Ann Francis, and Madhuri Koti. "STING Agonist Therapy in Combination With PD-1 Immune Checkpoint Blockade Enhances Response to Carboplatin Chemotherapy in High-grade Serous Ovarian Cancer." Br J Cancer 2018.

Ghaffari, Abdi, et al. "STING Agonist Therapy in Combination With PD-1 Immune Checkpoint Blockade Enhances Response to Carboplatin Chemotherapy in High-grade Serous Ovarian Cancer." Br J Cancer 2018.